Interstitial lung disease

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, Oliver Distler

Annals of the Rheumatic Diseases Jun 2015, 74 (6) 1188-1194; DOI: 10.1136/annrheumdis-2013-204522
Up regulated expression of fractalkine/CX₃CL1 and CX₃CR1 in patients with systemic sclerosis
M Hasegawa, S Sato, T Echigo, Y Hamaguchi, M Yasui, K Takehara

Annals of the Rheumatic Diseases Jan 2005, 64 (1) 21-28; DOI: 10.1136/ard.2003.018705
A9.02 Heat shock protein 90 plasma levels correlate with disease activity, skeletal muscle, lung and heart involvement in idiopathic inflammatory myopathies
H Storkanova, O Krystufkova, M Klein, H Mann, L Vernerova, M Spiritovic, J Zamecnik, K Pavelka, L Senolt, J Vencovsky, M Tomcik

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A70-A71; DOI: 10.1136/annrheumdis-2016-209124.168
Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe
R A Watts, M A Gonzalez-Gay, S E Lane, C Garcia-Porrua, G Bentham, D G I Scott

Annals of the Rheumatic Diseases Feb 2001, 60 (2) 170-172; DOI: 10.1136/ard.60.2.170
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population
P Dieudé, M Guedj, J Wipff, B Ruiz, G Riemekasten, M Matucci-Cerinic, I Melchers, E Hachulla, P Airo, E Diot, N Hunzelmann, J Cabane, L Mouthon, J L Cracowski, V Riccieri, J Distler, O Meyer, A Kahan, C Boileau, Y Allanore

Annals of the Rheumatic Diseases Nov 2010, 69 (11) 1958-1964; DOI: 10.1136/ard.2009.127928
A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature
Søren Freiesleben Sørensen, Ole Slot, Niels Tvede, Jørgen Petersen

Annals of the Rheumatic Diseases Jun 2000, 59 (6) 478-482; DOI: 10.1136/ard.59.6.478
Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype
L van Bon, M Cossu, A Loof, F Gohar, H Wittkowski, M Vonk, J Roth, W van den Berg, W van Heerde, J C A Broen, T R D J Radstake

Annals of the Rheumatic Diseases Aug 2014, 73 (8) 1585-1589; DOI: 10.1136/annrheumdis-2013-205013
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice
Mirko Manetti, Irene Rosa, Marilena Fazi, Serena Guiducci, Peter Carmeliet, Lidia Ibba-Manneschi, Marco Matucci-Cerinic

Annals of the Rheumatic Diseases Feb 2016, 75 (2) 474-478; DOI: 10.1136/annrheumdis-2015-207803
Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity
L Carmona, I González-Álvaro, A Balsa, M Angel Belmonte, X Tena, R Sanmartí, EMECAR Study Group

Annals of the Rheumatic Diseases Sep 2003, 62 (9) 897-900; DOI: 10.1136/ard.62.9.897
Severe impaired respiratory ciliary function in Wegener granulomatosis
S Ullrich, H Gustke, P Lamprecht, W L Gross, U Schumacher, P Ambrosch, M Laudien

Annals of the Rheumatic Diseases Jun 2009, 68 (6) 1067-1071; DOI: 10.1136/ard.2008.096974

Main menu

Interstitial lung disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Interstitial lung disease

Pages